BIOPHYTIS SA: Biophytis Announces Pricing of $20.1 Million U.S. Initial Public Offering of American Depositary Shares and Approval to List on Nasdaq Capital Market
Biophytis or the
Company ), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases, including severe respiratory failure in patients suffering from COVID-19, today announces the pricing of its previously announced U.S. initial public offering of 12,000,000 new ordinary shares represented by 1,200,000 American Depositary Shares (
ADSs ), with each ADS representing 10 ordinary shares, at an initial public offering price of $16.75 per ADS (the
Regulatory News: On February 8, 2021, the Board of Directors, under the conditions set forth at the Extraordinary Shareholders' Meeting of May 26, 2017, decided to decrease the share capital of TOTAL
announces its plan to acquire the entire capital and voting rights of US-based
Gerber Technology. A key Industry 4.0 player in the fashion, automotive and furniture industries, Lectra designs smart industrial solutions – software, equipment, data and services – that help brands, manufacturers and retailers develop, produce and market their products.
The acquisition, if and when consummated, would allow Lectra to complement its market position and continue to enhance its offerings based on Industry 4.0 technology that will enable its customers to boost the productivity and profitability of their operations. After the French work council of Lectra is consulted and the binding documentation is signed, completion of the acquisition shall remain subject to merger control clearance and other customary conditions and shall be submitted to Lectra shareholders for approval.
RUBIS: Capital increase reserved for Group s employees
DJ RUBIS: Capital increase reserved for Group s employees
RUBIS
RUBIS: Capital increase reserved for Group s employees
05-Feb-2021 / 17:35 CET/CEST
Dissemination of a French Regulatory News, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
=
Paris, February 5, 2021 - 5:35 pm
The Board of Management, at its meeting of January 4, 2021, decided to make use of the authorization granted by the
Ordinary and Extraordinary Shareholders Meeting of June 11, 2019, established under Articles L. 3332-18 et seq. of the
French Labor Code, to perform a capital increase by issuing shares reserved for eligible employees of companies